<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03297164</url>
  </required_header>
  <id_info>
    <org_study_id>2016YFC1301101</org_study_id>
    <nct_id>NCT03297164</nct_id>
  </id_info>
  <brief_title>Incidence Rate of Heart Failure After Acute Myocardial Infarction With Optimal Treatment</brief_title>
  <official_title>One Year Incidence Rate of Heart Failure After Acute Myocardial Infarction With Optimal Treatment-A Prospective,Multicenter,Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Harbin Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Harbin Medical University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The main purpose of this study is to build a multi-center, prospective and regionally
      representative acute myocardial infarction(AMI) cohort，and build a study platform for heart
      failure caused by AMI; To explore the 1 year incidence rate of heart failure after AMI given
      the optimized treatment and the treatment model affecting the incidence rate of heart
      failure, and finally to reduce the incidence rate of heart failure by 5%.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      the study aim to enroll 12000 acute myocardial infartion (AMI) patients, including ST-segment
      elevation myocardial infarction (STEMI) and non ST-segment elevation myocardial infarction
      (NSETMI), Patients were divided into two groups(optimized group and un-optimized group)
      according to treatment models they accepted in 20 reginally representative hosptials of
      China. whether optimizaed or not is judged by 4 four aspects,including emergency treatment
      procedure, pre-infusion medication, reperfusion strategy selection, and early rehabilitation
      after reperfusion.Patients were followed at 1 month, 6 months and 12 months. The physical
      condition and clinical events(heart failure, death, re-infarction, revascularization,
      apoplexy, malignant arrhythmias, bleeding events, other adverse events)were collected at
      follow up.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">December 21, 2017</start_date>
  <completion_date type="Anticipated">December 2019</completion_date>
  <primary_completion_date type="Anticipated">December 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>incidence rate of heart failure</measure>
    <time_frame>12th month after diacharge</time_frame>
    <description>incidence rate of heart failure of acute myocardial infarction at 12th month</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>MACCE rate</measure>
    <time_frame>12th month after diacharge</time_frame>
    <description>the major adverse cardiac celebral events including death,reinfarction,</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>bleeding rate</measure>
    <time_frame>12th month after diacharge</time_frame>
    <description>the incidence rate of bleeding</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>severe adverse drug reactions</measure>
    <time_frame>12th month after diacharge</time_frame>
    <description>severe adverse drug reactions at 12th month</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">12000</enrollment>
  <condition>Acute Myocardial Infarction</condition>
  <condition>Heart Failure</condition>
  <arm_group>
    <arm_group_label>optimized group</arm_group_label>
    <description>the patients in this group have been given the suggestive treatment from guideline.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>un-optimized group</arm_group_label>
    <description>the patients in this group have not been given the suggestive treatment from guideline.</description>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        acute myocadial infarction
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  age≥18 years

          -  diagnosed acute myocardial infarction

          -  signed the informed consent form

        Exclusion Criteria:

          -  AMI is caused by surgery, trauma, gastrointestinal bleeding or complications of PCI;

          -  AMI occurred in patients who have been hospitalized for other reasons;

          -  patients with previous history of chronic heart failure;

          -  researchers judging that patient's compliance was poor and could not complete the
             study according to the requirements.

          -  life expectancy is less than 12 months;

          -  heart transplant patients;

          -  patients with tumors;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Bo Yu, MD,PhD</last_name>
    <phone>+86-0451-86605800</phone>
    <email>yubodr@163.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Haibo Jia, MD,PhD</last_name>
    <phone>+86-0451-86605359</phone>
    <email>jhb101180@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Beijing An Zhen Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100029</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chunmei Wang</last_name>
      <email>wangchunmei0214@sina.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Peking Univerisity People'Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <zip>100044</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Weimin Wang</last_name>
      <email>weiminwang@vip.sina.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Beijing Chao-Yang Hospital, Capital Medical University</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lefeng Wang</last_name>
      <email>wlf311@sohu.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Peking University First Hospital</name>
      <address>
        <city>Beijing</city>
        <state>Beijing</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jianping Li</last_name>
      <email>lijianping@medmail.com.cn</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Guangdong general hospital</name>
      <address>
        <city>Guangzhou</city>
        <state>Guangdong</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ning Tan</last_name>
      <email>tanning100@126.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The first affiliated hospital of Guangxi medical university</name>
      <address>
        <city>Nanning</city>
        <state>Guangxi</state>
        <zip>530021</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lang Li</last_name>
      <email>drlilang@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Second hospital of hebei medical university</name>
      <address>
        <city>Shijiazhuang</city>
        <state>Hebei</state>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Xinshun Gu</last_name>
      <email>348220248@qq.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Daqing Oilfield General Hospital</name>
      <address>
        <city>Daqing</city>
        <state>Heilongjiang</state>
        <zip>163001</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Hui Li</last_name>
      <email>huilee_2006@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The first affiliated hospital of Zhengzhou medical university</name>
      <address>
        <city>Zhengzhou</city>
        <state>Henan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Ling Li</last_name>
      <email>liling63035@sina.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Zhongda Hospital Southeast University</name>
      <address>
        <city>Nanjing</city>
        <state>Jiangsu</state>
        <zip>210009</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Genshan Ma</last_name>
      <email>magenshan@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Second Affiliated Hospital of Nanchang University</name>
      <address>
        <city>Nanchang</city>
        <state>Jiangxi</state>
        <zip>330006</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yanqing Wu</last_name>
      <email>wuyanqing01@sina.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The Second Hospital of Jilin University</name>
      <address>
        <city>Changchun</city>
        <state>Jilin</state>
        <zip>130000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bin Liu</last_name>
      <email>liubin3333@vip.sina.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>the second affiliated hospital of Dalian medical university</name>
      <address>
        <city>Dalian</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Peng Qu</last_name>
      <email>qupeng777@aliyun.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Shenyang military district general hospital of the people's liberation army</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Bin Wang</last_name>
      <email>wangbindl@hotmail.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The first affiliated hospital of military medical university</name>
      <address>
        <city>Xi'an</city>
        <state>Shanxi</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Zhijing Zhao</last_name>
      <email>zhaozhj@fmmu.edu.cn</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Third Military Medical University</name>
      <address>
        <city>Chongqing</city>
        <state>Sichuan</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Jun Jin</last_name>
      <email>jjxqyy@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>Tianjin Chest Hospital</name>
      <address>
        <city>Tianjing</city>
        <state>Tianjin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Chunjie Li</last_name>
      <email>ykwn@sina.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The General Hospital of Tianjin Medical University</name>
      <address>
        <city>Tianjin</city>
        <state>Tianjin</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Wenjuan Zhang</last_name>
      <email>zwjzyy2013@163.com</email>
    </contact>
  </location>
  <location>
    <facility>
      <name>The First Affiliated Hospital of Xinjiang Medical University</name>
      <address>
        <city>Urumqi</city>
        <state>Xinjiang</state>
        <country>China</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Yining Yang</last_name>
      <email>yangyn5126@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 26, 2017</study_first_submitted>
  <study_first_submitted_qc>September 26, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">September 29, 2017</study_first_posted>
  <last_update_submitted>February 5, 2018</last_update_submitted>
  <last_update_submitted_qc>February 5, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 6, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Harbin Medical University</investigator_affiliation>
    <investigator_full_name>Yu Bo</investigator_full_name>
    <investigator_title>director</investigator_title>
  </responsible_party>
  <keyword>acute myocardial infarction</keyword>
  <keyword>heart failure</keyword>
  <keyword>optimized treatment</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Heart Failure</mesh_term>
    <mesh_term>Infarction</mesh_term>
    <mesh_term>Myocardial Infarction</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

